Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2026-04-12 @ 7:20 AM
Study NCT ID:
NCT02251860
Status:
COMPLETED
Last Update Posted:
2020-09-22
First Post:
2014-09-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Tocilizumab (RoActemre) Administered Subcutaneously in Participants With Rheumatoid Arthritis in Everyday Clinical Practice
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05-20
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-23
Completion Date Type:
ACTUAL
First Submit Date:
2014-09-25
First Submit QC Date:
None
Study First Post Date:
2014-09-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-21
Last Update Post Date:
2020-09-22
Last Update Post Date Type:
ACTUAL